Erica J. Duncan, M.D. - Publications

Psychiatry and Behavioral Sciences Emory University School of Medicine, Atlanta, GA, United States 
Schizophrenia, acoustic startle

67 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Lori A, Avramopoulos D, Wang AW, Mulle J, Massa N, Duncan EJ, Powers A, Conneely K, Gillespie CF, Jovanovic T, Ressler KJ, Pearce BD. Polygenic risk scores differentiate schizophrenia patients with toxoplasma gondii compared to toxoplasma seronegative patients. Comprehensive Psychiatry. 107: 152236. PMID 33721583 DOI: 10.1016/j.comppsych.2021.152236  0.92
2019 Jovanovic T, Duncan EJ, Kaye J, Garza K, Norrholm SD, Inslicht SS, Neylan TC, Mathew SJ, Iosifescu D, Rothbaum BO, Mayberg HS, Dunlop BW. Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients. Psychophysiology. e13356. PMID 30807663 DOI: 10.1111/Psyp.13356  0.92
2016 Wheeler MG, Duncan E, Davis M. Low Startle Magnitude May Be a Behavioral Marker of Vulnerability to Cocaine Addiction. Synapse (New York, N.Y.). PMID 27696533 DOI: 10.1002/Syn.21943  0.92
2016 Norrholm SD, Jovanovic T, Gerardi M, Breazeale KG, Price M, Davis M, Duncan E, Ressler KJ, Bradley B, Rizzo A, Tuerk PW, Rothbaum BO. Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. Behaviour Research and Therapy. 82: 28-37. PMID 27183343 DOI: 10.1016/J.Brat.2016.05.002  0.92
2014 Dunlop BW, Rothbaum BO, Binder EB, Duncan E, Harvey PD, Jovanovic T, Kelley ME, Kinkead B, Kutner M, Iosifescu DV, Mathew SJ, Neylan TC, Kilts CD, Nemeroff CB, Mayberg HS. Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial. Trials. 15: 240. PMID 24950747 DOI: 10.1186/1745-6215-15-240  0.92
2014 Rothbaum BO, Price M, Jovanovic T, Norrholm SD, Gerardi M, Dunlop B, Davis M, Bradley B, Duncan EJ, Rizzo A, Ressler KJ. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. The American Journal of Psychiatry. 171: 640-8. PMID 24743802 DOI: 10.1176/Appi.Ajp.2014.13121625  0.92
2013 Pearce BD, Hubbard S, Rivera HN, Wilkins PP, Fisch MC, Hopkins MH, Hasenkamp W, Gross R, Bliwise N, Jones JL, Duncan E. Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controls. Schizophrenia Research. 150: 258-61. PMID 23953218 DOI: 10.1016/J.Schres.2013.07.028  0.92
2013 Cadenhead KS, Addington J, Cannon TD, Cornblatt BA, de la Fuente-Sandoval C, Mathalon DH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bachman P, Belger A, Carrión RE, Donkers FC, ... Duncan E, et al. Between-site reliability of startle prepulse inhibition across two early psychosis consortia. Neuroreport. 24: 626-30. PMID 23799460 DOI: 10.1097/Wnr.0B013E3283637845  0.92
2013 Glover EM, Mercer KB, Norrholm SD, Davis M, Duncan E, Bradley B, Ressler KJ, Jovanovic T. Inhibition of fear is differentially associated with cycling estrogen levels in women. Journal of Psychiatry & Neuroscience : Jpn. 38: 341-8. PMID 23611176 DOI: 10.1503/Jpn.120129  0.92
2013 Koola MM, Qualls C, Kelly DL, Skelton K, Bradley B, Amar R, Duncan EJ. Prevalence of childhood physical and sexual abuse in veterans with psychiatric diagnoses. The Journal of Nervous and Mental Disease. 201: 348-52. PMID 23538982 DOI: 10.1097/Nmd.0B013E318288E333  0.92
2013 Jovanovic T, Sakoman AJ, Kozarić-Kovačić D, MeÅ¡trović AH, Duncan EJ, Davis M, Norrholm SD. Acute stress disorder versus chronic posttraumatic stress disorder: inhibition of fear as a function of time since trauma. Depression and Anxiety. 30: 217-24. PMID 22907890 DOI: 10.1002/Da.21991  0.92
2012 Duncan EJ, Woolson SL, Hamer RM. Treatment compliance in veterans administration schizophrenia spectrum patients treated with risperidone long-acting injectable. International Clinical Psychopharmacology. 27: 283-90. PMID 22644368 DOI: 10.1097/Yic.0B013E328354B534  0.92
2012 Koola MM, Brown WV, Qualls C, Cuthbert B, Hollis JP, Kelly DL, Le NA, Raines J, Duncan EJ. Reduced arterial compliance in patients with psychiatric diagnoses. Schizophrenia Research. 137: 251-3. PMID 22377105 DOI: 10.1016/J.Schres.2012.02.007  0.92
2012 Kamkwalala A, Norrholm SD, Poole JM, Brown A, Donley S, Duncan E, Bradley B, Ressler KJ, Jovanovic T. Dark-enhanced startle responses and heart rate variability in a traumatized civilian sample: putative sex-specific correlates of posttraumatic stress disorder. Psychosomatic Medicine. 74: 153-9. PMID 22286850 DOI: 10.1097/Psy.0B013E318240803A  0.92
2012 Hasenkamp W, Wilson-Mendenhall CD, Duncan E, Barsalou LW. Mind wandering and attention during focused meditation: a fine-grained temporal analysis of fluctuating cognitive states. Neuroimage. 59: 750-60. PMID 21782031 DOI: 10.1016/J.Neuroimage.2011.07.008  0.92
2012 Vahabzadeh A, Duncan E. Caution with prazosin Current Psychiatry. 11: E1-E2.  0.92
2011 Norrholm SD, Anderson KM, Olin IW, Jovanovic T, Kwon C, Warren VT, McCarthy A, Bosshardt L, Sabree J, Duncan EJ, Rothbaum BO, Bradley B. Versatility of fear-potentiated startle paradigms for assessing human conditioned fear extinction and return of fear. Frontiers in Behavioral Neuroscience. 5: 77. PMID 22125516 DOI: 10.3389/Fnbeh.2011.00077  0.92
2011 Egan GJ, Hasenkamp W, Wilcox L, Green A, Hsu N, Boshoven W, Lewison B, Keyes MD, Duncan E. Declarative memory and WCST-64 performance in subjects with schizophrenia and healthy controls. Psychiatry Research. 188: 191-6. PMID 21481945 DOI: 10.1016/J.Psychres.2011.02.026  0.92
2011 Hasenkamp W, Kelley M, Egan G, Green A, Wilcox L, Boshoven W, Lewison B, Duncan E. Lack of relationship between acoustic startle and cognitive variables in schizophrenia and control subjects. Psychiatry Research. 187: 324-8. PMID 21397338 DOI: 10.7490/F1000Research.1830.1  0.92
2011 Corcoran S, Norrholm SD, Cuthbert B, Sternberg M, Hollis J, Duncan E. Acoustic startle reduction in cocaine dependence persists for 1 year of abstinence. Psychopharmacology. 215: 93-103. PMID 21161186 DOI: 10.1007/S00213-010-2114-2  0.92
2011 Hasenkamp W, James GA, Boshoven W, Duncan E. Altered engagement of attention and default networks during target detection in schizophrenia. Schizophrenia Research. 125: 169-73. PMID 20869846 DOI: 10.1016/J.Schres.2010.08.041  0.92
2010 Hasenkamp W, Epstein MP, Green A, Wilcox L, Boshoven W, Lewison B, Duncan E. Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families. Psychiatry Research. 178: 236-43. PMID 20483176 DOI: 10.1016/J.Psychres.2009.11.012  0.92
2010 Jovanovic T, Norrholm SD, Blanding NQ, Davis M, Duncan E, Bradley B, Ressler KJ. Impaired fear inhibition is a biomarker of PTSD but not depression. Depression and Anxiety. 27: 244-51. PMID 20143428 DOI: 10.1002/Da.20663  0.92
2010 Jovanovic T, Norrholm SD, Blanding NQ, Phifer JE, Weiss T, Davis M, Duncan E, Bradley B, Ressler K. Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD. Psychoneuroendocrinology. 35: 846-57. PMID 20036466 DOI: 10.1016/J.Psyneuen.2009.11.009  0.92
2010 Jovanovic T, Norrholm SD, Fennell JE, Keyes M, Fiallos AM, Myers KM, Davis M, Duncan EJ. Posttraumatic stress disorder may be associated with impaired fear inhibition: Relation to symptom severity | El trastorno de estrés postraumático puede asociarse a un deterioro de la inhibición del temor: relación con la gravedad de los síntomas Psiquiatria Biologica. 17: 119-126. DOI: 10.1016/J.Psiq.2010.12.001  0.92
2010 Norrholm SD, Jovanovic T, Rothbaum BO, Davis M, Hasenkamp W, Crowe C, Duncan E, Leimbach L, Skelton K, Bradley B. Optimization of research and clinical applications for combat-related posttraumatic stress disorder (PTSD): Progress through modern translational methodologies Optimization of Research and Clinical Applications For Combat-Related Posttraumatic Stress Disorder (Ptsd): Progress Through Modern Translational Methodologies. 1-63.  0.92
2009 Jovanovic T, Blanding NQ, Norrholm SD, Duncan E, Bradley B, Ressler KJ. Childhood abuse is associated with increased startle reactivity in adulthood. Depression and Anxiety. 26: 1018-26. PMID 19691032 DOI: 10.1002/Da.20599  0.92
2009 Duncan EJ, Woolson SL, Hamer RM, Dunlop BW. Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population. International Clinical Psychopharmacology. 24: 204-13. PMID 19494785 DOI: 10.1097/Yic.0B013E32832D6C18  0.92
2009 Jovanovic T, Norrholm SD, Fennell JE, Keyes M, Fiallos AM, Myers KM, Davis M, Duncan EJ. Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity. Psychiatry Research. 167: 151-60. PMID 19345420 DOI: 10.1016/J.Psychres.2007.12.014  0.92
2008 Norrholm SD, Vervliet B, Jovanovic T, Boshoven W, Myers KM, Davis M, Rothbaum B, Duncan EJ. Timing of extinction relative to acquisition: a parametric analysis of fear extinction in humans. Behavioral Neuroscience. 122: 1016-30. PMID 18823159 DOI: 10.1037/A0012604  0.92
2008 Hasenkamp W, Norrholm SD, Green A, Lewison B, Boshoven W, Keyes M, Duncan E. Differences in startle reflex and prepulse inhibition in European-Americans and African-Americans. Psychophysiology. 45: 876-82. PMID 18665868 DOI: 10.1111/J.1469-8986.2008.00680.X  0.92
2007 Duncan E, Boshoven W, Harenski K, Fiallos A, Tracy H, Jovanovic T, Hu X, Drexler K, Kilts C. An fMRI study of the interaction of stress and cocaine cues on cocaine craving in cocaine-dependent men. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 16: 174-82. PMID 17612820 DOI: 10.1080/10550490701375285  0.92
2007 Shipherd JC, Keyes M, Jovanovic T, Ready DJ, Baltzell D, Worley V, Gordon-Brown V, Hayslett C, Duncan E. Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? Journal of Rehabilitation Research and Development. 44: 153-66. PMID 17551870 DOI: 10.1682/Jrrd.2006.06.0065  0.92
2007 Mittal VA, Hasenkamp W, Sanfilipo M, Wieland S, Angrist B, Rotrosen J, Duncan EJ. Relation of neurological soft signs to psychiatric symptoms in schizophrenia. Schizophrenia Research. 94: 37-44. PMID 17543502 DOI: 10.1016/J.Schres.2007.04.017  0.92
2007 Duncan E, Dunlop BW, Boshoven W, Woolson SL, Hamer RM, Phillips LS. Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population International Clinical Psychopharmacology. 22: 1-11. PMID 17159454 DOI: 10.1097/01.Yic.0000224792.44276.20  0.92
2006 Norrholm SD, Jovanovic T, Vervliet B, Myers KM, Davis M, Rothbaum BO, Duncan EJ. Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. Learning & Memory (Cold Spring Harbor, N.Y.). 13: 681-5. PMID 17142300 DOI: 10.1101/Lm.393906  0.92
2006 Duncan EJ, Bollini AM, Lewison B, Keyes M, Jovanovic T, Gaytan O, Egan G, Szilagyi S, Schwartz M, Parwani A, Chakravorty S, Rotrosen J. Medication status affects the relationship of symptoms to prepulse inhibition of acoustic startle in schizophrenia. Psychiatry Research. 145: 137-45. PMID 17070928 DOI: 10.1016/j.psychres.2006.04.006  0.92
2006 Jovanovic T, Norrholm SD, Keyes M, Fiallos A, Jovanovic S, Myers KM, Davis M, Duncan EJ. Contingency awareness and fear inhibition in a human fear-potentiated startle paradigm. Behavioral Neuroscience. 120: 995-1004. PMID 17014251 DOI: 10.1037/0735-7044.120.5.995  0.92
2006 George TP, Termine A, Sacco KA, Allen TM, Reutenauer E, Vessicchio JC, Duncan EJ. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophrenia Research. 87: 307-15. PMID 16854565 DOI: 10.1016/J.Schres.2006.05.022  0.92
2006 Duncan E, Bollini AM, Sanfilipo M, Wieland S, Angrist B, Cooper TB, Rotrosen J. Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls. Schizophrenia Research. 81: 323-6. PMID 16181774 DOI: 10.1016/J.Schres.2005.08.001  0.92
2005 Jovanovic T, Keyes M, Fiallos A, Myers KM, Davis M, Duncan EJ. Fear potentiation and fear inhibition in a human fear-potentiated startle paradigm. Biological Psychiatry. 57: 1559-64. PMID 15953493 DOI: 10.1016/J.Biopsych.2005.02.025  0.92
2004 Duncan EJ, Szilagyi S, Schwartz MP, Bugarski-Kirola D, Kunzova A, Negi S, Stephanides M, Efferen TR, Angrist B, Peselow E, Corwin J, Gonzenbach S, Rotrosen JP. Effects of D-cycloserine on negative symptoms in schizophrenia. Schizophrenia Research. 71: 239-48. PMID 15474895 DOI: 10.1016/J.Schres.2004.03.013  0.92
2004 Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A, Schwartz MP, Gonzenbach S, Rotrosen JP, Duncan EJ. Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology. 41: 401-6. PMID 15102125 DOI: 10.1111/1469-8986.2004.00166.X  0.92
2003 Dunlop BW, Sternberg M, Phillips LS, Andersen J, Duncan E. Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics Psychopharmacology Bulletin. 37: 99-117. PMID 14608243  0.92
2003 Duncan E, Szilagyi S, Schwartz M, Kunzova A, Negi S, Efferen T, Peselow E, Chakravorty S, Stephanides M, Harmon J, Bugarski-Kirola D, Gonzenbach S, Rotrosen J. Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol Psychiatry Research. 120: 1-12. PMID 14500109 DOI: 10.1016/S0165-1781(03)00161-6  0.92
2003 Duncan EJ, Szilagyi S, Efferen TR, Schwartz MP, Parwani A, Chakravorty S, Madonick SH, Kunzova A, Harmon JW, Angrist B, Gonzenbach S, Rotrosen JP. Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Psychopharmacology. 167: 63-71. PMID 12632245 DOI: 10.1007/S00213-002-1372-Z  0.92
2002 Duncan EJ, Brown A, Lundy P, Sawyer TW, Hamilton M, Hill I, Conley JD. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine. Journal of Applied Toxicology : Jat. 22: 141-8. PMID 12015792 DOI: 10.1002/jat.838  0.4
2001 Duncan E, Madonick S, Chakravorty S, Parwani A, Szilagyi S, Efferen T, Gonzenbach S, Angrist B, Rotrosen J. Effects of smoking on acoustic startle and prepulse inhibition in humans Psychopharmacology. 156: 266-272. PMID 11549228 DOI: 10.1007/S002130100719  0.92
2001 Adams JU, Efferen TR, Duncan EJ, Rotrosen J. Prepulse inhibition of the acoustic startle response in cocaine-withdrawn rats. Pharmacology, Biochemistry, and Behavior. 68: 753-9. PMID 11526973 DOI: 10.1016/S0091-3057(01)00478-6  0.92
2001 Duncan EJ, Madonick SH, Parwani A, Angrist B, Rajan R, Chakravorty S, Efferen TR, Szilagyi S, Stephanides M, Chappell PB, Gonzenbach S, Ko GN, Rotrosen JP. Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 72-83. PMID 11377920 DOI: 10.1016/S0893-133X(00)00240-2  0.92
2000 Duncan EJ, Adler LA, Stephanides M, Sanfilipo M, Angrist B. Akathisia and exacerbation of psychopathology: a preliminary report. Clinical Neuropharmacology. 23: 169-73. PMID 10895402 DOI: 10.1097/00002826-200005000-00008  0.92
2000 Parwani A, Duncan EJ, Bartlett E, Madonick SH, Efferen TR, Rajan R, Sanfilipo M, Chappell PB, Chakravorty S, Gonzenbach S, Ko GN, Rotrosen JP. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biological Psychiatry. 47: 662-9. PMID 10745060 DOI: 10.1016/S0006-3223(99)00148-1  0.92
2000 Efferen TR, Duncan EJ, Szilagyi S, Chakravorty S, Adams JU, Gonzenbach S, Angrist B, Butler PD, Rotrosen J. Diminished acoustic startle in chronic cocaine users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 89-96. PMID 10633494 DOI: 10.1016/S0893-133X(99)00089-5  0.92
1998 Adler LA, Edson R, Lavori P, Peselow E, Duncan E, Rosenthal M, Rotrosen J. Long-term treatment effects of vitamin E for tardive dyskinesia Biological Psychiatry. 43: 868-872. PMID 9627740 DOI: 10.1016/S0006-3223(97)00027-9  0.92
1996 Sanfilipo M, Wolkin A, Angrist B, Van Kammen DP, Duncan E, Wieland S, Cooper TB, Peselow ED, Rotrosen J. Amphetamine and negative symptoms of schizophrenia Psychopharmacology. 123: 211-214. PMID 8741946 DOI: 10.1007/Bf02246180  0.92
1996 Wolkin A, Sanfilipo M, Duncan E, Angrist B, Wolf AP, Cooper TB, Brodie JD, Laska E, Rotrosen JP. Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. The American Journal of Psychiatry. 153: 346-54. PMID 8610821 DOI: 10.1176/Ajp.153.3.346  0.92
1994 Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Cooper TB, Laska E, Rotrosen JP. Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology. Biological Psychiatry. 36: 317-25. PMID 7993958 DOI: 10.1016/0006-3223(94)90629-7  0.92
1994 Wolkin A, Duncan E, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J. Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function Journal of Neural Transmission. 95: 49-61. PMID 7857586 DOI: 10.1007/Bf01283030  0.92
1993 Noponen M, Sanfilipo M, Samanich K, Ryer H, Ko G, Angrist B, Wolkin A, Duncan E, Rotrosen J. Elevated PLA2 activity in schizophrenics and other psychiatric patients Biological Psychiatry. 34: 641-649. PMID 8292693 DOI: 10.1016/0006-3223(93)90157-9  0.92
1993 Duncan E, Wolkin A, Angrist B, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics Biological Psychiatry. 34: 523-528. PMID 8274579 DOI: 10.1016/0006-3223(93)90194-I  0.92
1993 Adler LA, Peselow E, Duncan E, Rosenthal M, Angrist B. Vitamin E in tardive dyskinesia: Time course of effect after placebo substitution Psychopharmacology Bulletin. 29: 371-374. PMID 8121964  0.92
1993 Adler LA, Peselow E, Rotrosen J, Duncan E, Lee M, Rosenthal M, Angrist B. Vitamin E treatment of tardive dyskinesia American Journal of Psychiatry. 150: 1405-1407. PMID 8102511 DOI: 10.1176/Ajp.150.9.1405  0.92
1989 Adler LA, Duncan E, Kim A, Hemdal P, Rotrosen J, Angrist B. Selected posters-summaries akathisia: Selective b-blockers and rating instruments Psychopharmacology Bulletin. 25: 451-456. PMID 2576321  0.92
1989 Adler LA, Duncan E, Reiter S, Rotrosen J, Angrist B. Treatment of extrapyramidal side-effects British Journal of Psychiatry. 155: 269. PMID 2574614 DOI: 10.1192/Bjp.155.2.269A  0.92
1989 Adler L, Duncan E, Angrist B, Hemdal P, Rotrosen J, Slotnick V. Effects of a specific beta2-receptor blocker in neuroleptic-induced akathisia Psychiatry Research. 27: 1-4. PMID 2564208 DOI: 10.1016/0165-1781(89)90002-4  0.92
1988 Adler L, Duncan E, Reiter S, Angrist B, Peselow E, Rotrosen J. Effects of calcium-channel antagonsits on tardive dyskinesia and psychosis Psychopharmacology Bulletin. 24: 421-425. PMID 3153502  0.92
1987 Reiter S, Adler L, Erle S, Duncan E. Neuroleptic-induced akathisia treated with pindolol American Journal of Psychiatry. 144: 383-384. PMID 2881493 DOI: 10.1176/Ajp.144.3.383-B  0.92
Show low-probability matches.